Considering the tantalizing, potent tumor-specific killing ability of the TRAIL-induced extrinsic apoptosis pathway, further development of TRAIL-Trimer fusion protein is warranted as a potential advancement in cancer therapy. Here, TNFSF10 is linked to neoplasm.